Aveanna Healthcare (AVAH)
(Delayed Data from NSDQ)
$3.71 USD
+0.44 (13.46%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $3.70 -0.01 (-0.27%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$3.71 USD
+0.44 (13.46%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $3.70 -0.01 (-0.27%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Zacks News
Option Care (OPCH) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Option Care (OPCH) delivered earnings and revenue surprises of 23.53% and 1.99%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Aveanna Healthcare (AVAH) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Aveanna (AVAH) delivered earnings and revenue surprises of -50% and 0.66%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
LifeStance Health Group (LFST) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
LifeStance Health (LFST) delivered earnings and revenue surprises of 0% and 6.31%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Oak Street Health, Inc. (OSH) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Oak Street Health, Inc. (OSH) delivered earnings and revenue surprises of 9.68% and 1.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for January 12th
by Zacks Equity Research
APP, ACIW and ABM have been added to the Zacks Rank #5 (Strong Sell) List on January 12, 2023.
New Strong Sell Stocks for January 9th
by Zacks Equity Research
ADTN, AVAH and DBI have been added to the Zacks Rank #5 (Strong Sell) List on January 9, 2023.
New Strong Sell Stocks for January 4th
by Zacks Equity Research
AVAH, CBRL and ILMN have been added to the Zacks Rank #5 (Strong Sell) List on January 4, 2023.
Aveanna Healthcare (AVAH) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Aveanna (AVAH) delivered earnings and revenue surprises of -175% and 1.30%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
ATI Physical Therapy, Inc. (ATIP) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
ATI Physical Therapy, Inc. (ATIP) delivered earnings and revenue surprises of -42.86% and 3.96%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Amedisys (AMED) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Amedisys (AMED) delivered earnings and revenue surprises of -7.26% and 3.41%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Aveanna Healthcare (AVAH) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Aveanna (AVAH) delivered earnings and revenue surprises of -50% and 3.03%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
RadNet (RDNT) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
RadNet (RDNT) delivered earnings and revenue surprises of 200% and 1.75%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
The Pennant Group, Inc. (PNTG) Meets Q2 Earnings Estimates
by Zacks Equity Research
The Pennant Group, Inc. (PNTG) delivered earnings and revenue surprises of 0% and 2.81%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Aveanna Healthcare (AVAH) Q2 Earnings Expected to Decline
by Zacks Equity Research
Aveanna (AVAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Encompass Health (EHC) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Encompass Health (EHC) delivered earnings and revenue surprises of -8.25% and 1.39%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Hanger (HNGR) Stock Jumps 25%: Will It Continue to Soar?
by Zacks Equity Research
Hanger (HNGR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
LifeStance Health (LFST) Soars 6.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
LifeStance Health (LFST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
The Pennant Group, Inc. (PNTG) Stock Jumps 6%: Will It Continue to Soar?
by Zacks Equity Research
The Pennant Group, Inc. (PNTG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Aveanna Healthcare (AVAH) Q1 Earnings Lag Estimates
by Zacks Equity Research
Aveanna (AVAH) delivered earnings and revenue surprises of -33.33% and 4.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Elanco Animal Health Incorporated (ELAN) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 2.86% and 0.71%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
DaVita HealthCare (DVA) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
DaVita HealthCare (DVA) delivered earnings and revenue surprises of -12.97% and 2.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
AlerisLife (ALR) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Five Star (ALR) delivered earnings and revenue surprises of -181.82% and 6.52%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
How Much Upside is Left in Aveanna (AVAH)? Wall Street Analysts Think 86%
by Zacks Equity Research
The consensus price target hints at an 85.6% upside potential for Aveanna (AVAH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
AVAH vs. ELAN: Which Stock Is the Better Value Option?
by Zacks Equity Research
AVAH vs. ELAN: Which Stock Is the Better Value Option?